ArticleFrontiers in veterinary science2024
Long-term ultrasonographic changes of the canine prostate gland after castration.
Article in Frontiers in veterinary science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Ultrasonographic Appearance of Acute Prostatitis and Prostatic Abscesses in Dogs.Animals : an open access journal from MDPI · 2026Article
- Comprehensive Insight into the Male Dog Reproductive System in Health and Diseases: Developmental, Genetic, and Environmental Factors-Review on Research and Clinical Trials.Veterinary sciences · 2026Review
- Emerging imaging modalities for the diagnosis of malignant lesions of the male reproductive tract in companion animals.Animal reproduction · 2026Review
- Evaluation of serum alpha-1B glycoprotein and C-reactive protein levels as biomarkers of canine benign prostatic hyperplasia.Veterinary world · 2025Article
- Is Canine Prostate-Specific Esterase a Reliable Marker for Benign Prostatic Hyperplasia Progression in Dogs?Animals : an open access journal from MDPI · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ultrasound imaging (US) is the method of choice to assess the canine prostate gland. Whilst recent studies have documented the role of castration in the development of prostatic neoplasia, little is known about parenchymal and perfusion features of the normal and abnormal prostate in neutered dogs. No data are available concerning prostatic changes after the first 90 days following castration. The present study aimed to acquire data on the long-term ultrasonographic changes occurring to the canine prostate after castration. Materials and methods: Ten adult neutered dogs underwent B-mode US and contrast-enhanced ultrasound (CEUS) of the prostate on two occasions: day of the first examination (T0) and six years later (T1). The prostate was evaluated via B-mode US and the volume was calculated using Atalan's formula. For CEUS examination, an intravenous contrast agent (SonoVue) was administered to assess prostatic perfusion. Videoclips were recorded, and time-intensity curves were obtained to determine contrast parameters: peak enhancement (PPI) and time to peak (TTP). Volumetric and perfusion results were then compared between timepoints. Results: At both examinations, the prostate appeared similar on B-mode US in terms of morphology and echotexture, minimally decreasing in volume over time. Prostate perfusion was significantly reduced in all dogs between T0 and T1, with a PPI decrease from 54.9 to 29.6% and an increase in TTP from 26.3 to 47 s. Discussion: These preliminary data provide baseline information on the B-mode appearance and CEUS measurements of the prostate gland of neutered dogs and suggest that prostatic involution after castration is not a short-term process but continues over several months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.